What an Indian pharma giant’s new drug find can gain the world’s obesity fight

By admin Jun26,2024

Dilip Shanghvi , founder, chairman and managing director, Sun Pharmaceutical Industries Limited.

Synopsis

Selling weight-loss drugs is an opportunity no pharma company wants to miss. Now a leading drug maker from India joins this bandwagon.

Trust Sun Pharma boss Dilip Shanghvi to be at the cutting-edge of research. After building a band of specialty drugs that exceeds a billion dollars in sales globally, Shanghvi has placed his bets on weight-loss or anti-obesity drugs, a field that has sent pharmaceutical companies across the world in a hot pursuit. Riding on blockbusters such as Ozempic, Wegovy, and Zepbound, their makers Novo Nordisk and Eli Lilly are ranked the most valuable

  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

New Feature
Refer & Earn

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

By admin

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *